Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liliane Goetsch

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
International Journal of Cancer|May 5, 2016
A novel antagonist anti-cMet antibody with antitumor activities targeting both ligand-dependent and ligand-independent c-Met receptorsAlexandra Gonzalez, Matthieu Broussas, Charlotte Beau-Larvor, et al.
Current Pharmaceutical Biotechnology|December 17, 2008
Trends in glycosylation, glycoanalysis and glycoengineering of therapeutic antibodies and Fc-fusion proteinsAlain Beck, Elsa Wagner-Rousset, Marie-Claire Bussat, et al.
International Journal of Cancer|August 14, 2012
A novel role for junctional adhesion molecule-A in tumor proliferation: modulation by an anti-JAM-A monoclonal antibodyLiliane Goetsch, Jean-François Haeuw, Charlotte Beau-Larvor, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|July 3, 2007
Peptides as tools and drugs for immunotherapiesAlain Beck, Christine Klinguer-Hamour, Marie-Claire Bussat, et al.
Virology|December 17, 2002
Passive transfer of serum antibodies induced by BBG2Na, a subunit vaccine, in the elderly protects SCID mouse lungs against respiratory syncytial virus challengeHélène Plotnicky-Gilquin, Dominique Cyblat-Chanal, Liliane Goetsch, et al.
Molecular Cancer Therapeutics|June 15, 2016
A New Anti-CXCR4 Antibody That Blocks the CXCR4/SDF-1 Axis and Mobilizes Effector CellsMatthieu Broussas, Nicolas Boute, Barbara Akla, et al.
BMC Cancer|February 17, 2016
Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplificationJieyi Wang, Liliane Goetsch, Lora Tucker, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
International Journal of Cancer|May 5, 2016
A novel antagonist anti-cMet antibody with antitumor activities targeting both ligand-dependent and ligand-independent c-Met receptorsAlexandra Gonzalez, Matthieu Broussas, Charlotte Beau-Larvor, et al.
Current Pharmaceutical Biotechnology|December 17, 2008
Trends in glycosylation, glycoanalysis and glycoengineering of therapeutic antibodies and Fc-fusion proteinsAlain Beck, Elsa Wagner-Rousset, Marie-Claire Bussat, et al.
International Journal of Cancer|August 14, 2012
A novel role for junctional adhesion molecule-A in tumor proliferation: modulation by an anti-JAM-A monoclonal antibodyLiliane Goetsch, Jean-François Haeuw, Charlotte Beau-Larvor, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|July 3, 2007
Peptides as tools and drugs for immunotherapiesAlain Beck, Christine Klinguer-Hamour, Marie-Claire Bussat, et al.
Virology|December 17, 2002
Passive transfer of serum antibodies induced by BBG2Na, a subunit vaccine, in the elderly protects SCID mouse lungs against respiratory syncytial virus challengeHélène Plotnicky-Gilquin, Dominique Cyblat-Chanal, Liliane Goetsch, et al.
Molecular Cancer Therapeutics|June 15, 2016
A New Anti-CXCR4 Antibody That Blocks the CXCR4/SDF-1 Axis and Mobilizes Effector CellsMatthieu Broussas, Nicolas Boute, Barbara Akla, et al.
BMC Cancer|February 17, 2016
Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplificationJieyi Wang, Liliane Goetsch, Lora Tucker, et al.
Pageof 3